SEPTIN9 and neoplasm: Multiplex qMSP analysis of Septin9, Epo, and MT-1A showed detection sensitivities of 85.49% (95% CI, 82.55%~88.01%) for overall (n = 641) patients, and the detection performance showed positive correlation with the tumor progression.